BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21471642)

  • 1. Increasing the diagnostic accuracy of medial temporal lobe atrophy in Alzheimer's disease.
    Jacobs HI; Van Boxtel MP; van der Elst W; Burgmans S; Smeets F; Gronenschild EH; Verhey FR; Uylings HB; Jolles J
    J Alzheimers Dis; 2011; 25(3):477-90. PubMed ID: 21471642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrophy of the parietal lobe in preclinical dementia.
    Jacobs HI; Van Boxtel MP; Uylings HB; Gronenschild EH; Verhey FR; Jolles J
    Brain Cogn; 2011 Mar; 75(2):154-63. PubMed ID: 21130554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal atrophy and cerebrovascular disease increase dementia risk among cognitively normal older adults.
    Rosano C; Aizenstein HJ; Wu M; Newman AB; Becker JT; Lopez OL; Kuller LH
    J Neuroimaging; 2007 Apr; 17(2):148-55. PubMed ID: 17441836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.
    Schmand B; Huizenga HM; van Gool WA
    Psychol Med; 2010 Jan; 40(1):135-45. PubMed ID: 19863841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer's disease.
    Uotani C; Sugimori K; Kobayashi K
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):319-26. PubMed ID: 16732748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
    Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
    Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grey-matter atrophy in Alzheimer's disease is asymmetric but not lateralized.
    Derflinger S; Sorg C; Gaser C; Myers N; Arsic M; Kurz A; Zimmer C; Wohlschläger A; Mühlau M
    J Alzheimers Dis; 2011; 25(2):347-57. PubMed ID: 21422522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-derived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer's disease.
    Thomann PA; Dos Santos V; Seidl U; Toro P; Essig M; Schröder J
    J Alzheimers Dis; 2009; 17(1):213-21. PubMed ID: 19494444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral volume loss, cognitive deficit and neuropsychological performance: comparative measures of brain atrophy: I. Dementia.
    Bigler ED; Neeley ES; Miller MJ; Tate DF; Rice SA; Cleavinger H; Wolfson L; Tschanz J; Welsh-Bohmer K
    J Int Neuropsychol Soc; 2004 May; 10(3):442-52. PubMed ID: 15147601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fronto-temporal-lobe atrophy in early-stage Alzheimer's disease identified using an improved detection methodology.
    Farrow TF; Thiyagesh SN; Wilkinson ID; Parks RW; Ingram L; Woodruff PW
    Psychiatry Res; 2007 May; 155(1):11-9. PubMed ID: 17399959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment.
    Bokde AL; Lopez-Bayo P; Meindl T; Pechler S; Born C; Faltraco F; Teipel SJ; Möller HJ; Hampel H
    Brain; 2006 May; 129(Pt 5):1113-24. PubMed ID: 16520329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease.
    Jang JW; Kim S; Na HY; Ahn S; Lee SJ; Kwak KH; Lee MA; Hsiung GY; Choi BS; Youn YC
    Eur Neurol; 2013; 69(4):229-35. PubMed ID: 23344183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefrontal cortex atrophy predicts dementia over a six-year period.
    Burgmans S; van Boxtel MP; Smeets F; Vuurman EF; Gronenschild EH; Verhey FR; Uylings HB; Jolles J
    Neurobiol Aging; 2009 Sep; 30(9):1413-9. PubMed ID: 18258339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease.
    Testa C; Laakso MP; Sabattoli F; Rossi R; Beltramello A; Soininen H; Frisoni GB
    J Magn Reson Imaging; 2004 Mar; 19(3):274-82. PubMed ID: 14994294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear measures of temporal lobe atrophy on brain magnetic resonance imaging (MRI) but not visual rating of white matter changes can help discrimination of mild cognitive impairment (MCI) and Alzheimer's disease (AD).
    Saka E; Dogan EA; Topcuoglu MA; Senol U; Balkan S
    Arch Gerontol Geriatr; 2007; 44(2):141-51. PubMed ID: 16723158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
    Meyer JS; Huang J; Chowdhury MH
    J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.